Common GLP-1 Side Effects According to clinical literature and FDA labeling for approved GLP-1 medications, commonly reported side effects include nausea (especially when starting or after dose increases), vomiting, diarrhea, constipation, abdominal discomfort, decreased appetite, fatigue, and injection site reactions (for injectables)
During Phase 1 detoxification, a family of enzymes known as Cytochrome P450 (CYP450) modifies toxins through oxidation
longum A 2025 randomized, double-blind, placebo-controlled trial reported that a Bifidobacterium breve strain significantly raised GLP-1 and fecal butyrate while improving insulin resistance in adults with obesity
quantiles of normal) are shown in Figures 3B,C
With cagrilintide
Avoid trigger foods : Spicy, fatty, or acidic foods may worsen reflux and taste disturbances